Regenerative Stem Cell Therapy: Good Alternative To Joint Replacement Surgery?

Seoul, Seoul / / October 9, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways Stem cell therapy offers a minimally invasive ...
PharmiWeb

Cell Therapy Market 2035: Driving Breakthroughs in Oncology and Regenerative Medicine

Cell Therapy Market Expansion Fueled by Rising Adoption of Stem Cell and Gene-Based Therapies WorldwideGlobal Cell Therapy ...

Non-Small Cell Lung Cancer Analysis Report 2025: Market Dominated by Roche, AstraZeneca, Merck, and Novartis, Fueled by Immuno-Oncology, Targeted Therapies, and Strategic ...

Opportunities in the NSCLC market include the adoption of targeted and immunotherapies such as PD-1/PD-L1 inhibitors, the potential in Asia Pacific driven by rising prevalence, and advancements in ...
Frontiers

Emerging role of CAR-T cell therapy in autoimmune rheumatic diseases: mechanisms, clinical progress, and future directions

Autoimmune rheumatic diseases (ARDs), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic ...
Managed Healthcare Executive

Outcomes Model Is Starting With Gene Therapy for Sickle Cell Disease

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)

First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications ...

Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI ...

ATNM-400 is advancing as a first-in-class, multi-tumor Actinium-225 radiotherapy candidate with activity across prostate and lung cancers, two of the largest cancer indications globally New ...